Education
About Us
Working with TipRanks
Follow Us
Cencora (COR)
NYSE:COR
COR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$218.65 - $309.35
Previous CloseN/A
Volume440.68K
Average Volume (3M)1.25M
Market Cap
$56.54B
Enterprise Value$64.73B
Total Cash (Recent Filing)$2.23B
Total Debt (Recent Filing)$8.24B
Price to Earnings (P/E)30.0
Beta0.12
Next Earnings
Nov 06, 2025EPS Estimate
3.79Last Dividend Ex-Date
Aug 15, 2025Dividend Yield0.75%
Share Statistics
EPS (TTM)4.00
Shares Outstanding193,877,880
10 Day Avg. Volume1,291,144
30 Day Avg. Volume1,252,972
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue0.20
Enterprise Value/Gross Profit6.67
Enterprise Value/Ebitda16.14
Forecast
1Y Price Target
$335.38Price Target Upside13.63% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe US Healthcare adjusted operating income growth estimate exceeds the company's long-term growth targets, suggesting strong momentum.
Growth PotentialThe stock is seen as having a durable growth story, with recent weaknesses viewed as overdone relative to this perspective.
Bears Say
Earnings ImpactThe loss of FCS and Publix could impact future earnings, despite overall positive growth estimates.
International PerformanceSoftness on the International side created a mathematical shortfall for the segment.
Cencora News
COR FAQ
What was Cencora’s price range in the past 12 months?
Cencora lowest stock price was $218.65 and its highest was $309.35 in the past 12 months.
What is Cencora’s market cap?
Cencora’s market cap is $56.54B.
When is Cencora’s upcoming earnings report date?
Cencora’s upcoming earnings report date is Nov 06, 2025 which is in 63 days.
How were Cencora’s earnings last quarter?
Cencora released its earnings results on Aug 06, 2025. The company reported $4 earnings per share for the quarter, beating the consensus estimate of $3.848 by $0.152.
Is Cencora overvalued?
According to Wall Street analysts Cencora’s price is currently Undervalued.
Does Cencora pay dividends?
Cencora pays a Quarterly dividend of $0.55 which represents an annual dividend yield of 0.75%. See more information on Cencora dividends here
What is Cencora’s EPS estimate?
Cencora’s EPS estimate is 3.79.
How many shares outstanding does Cencora have?
Cencora has 193,877,880 shares outstanding.
What happened to Cencora’s price movement after its last earnings report?
Cencora reported an EPS of $4 in its last earnings report, beating expectations of $3.848. Following the earnings report the stock price went down -2.93%.
Which hedge fund is a major shareholder of Cencora?
Currently, no hedge funds are holding shares in COR
Cencora Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$335.38 (13.63% Upside)
$335.38 (13.63% Upside)
Blogger Sentiment
Bullish
COR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 2.8%
Last 30 Days ▲ 2.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.10%
12-Months-Change
Fundamentals
Return on Equity
130.60%
Trailing 12-Months
Asset Growth
10.76%
Trailing 12-Months
Company Description
Cencora
Cencora (COR) is a global leader in the pharmaceutical supply chain, specializing in providing comprehensive services for the healthcare and life sciences sectors. The company operates in various segments, including logistics, distribution, and regulatory compliance, offering a suite of products and services designed to ensure the efficient delivery of pharmaceuticals and medical devices. Cencora focuses on enhancing supply chain performance for pharmaceutical manufacturers, healthcare providers, and patients through innovative solutions and robust infrastructure.
COR Company Deck
COR Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Cencora demonstrated strong financial performance and raised its fiscal guidance due to excellent execution in its U.S. Healthcare Solutions segment. However, challenges in the International Healthcare Solutions segment and increased net interest expenses pose concerns. Despite these challenges, the positive aspects significantly outweigh the negative, particularly due to strong specialty performance and increased revenue and profit.View all COR earnings summariesCOR Revenue Breakdown
89.54% U.S. Healthcare Solutions
10.46% International Healthcare Solutions
COR Stock 12 Month Forecast
Average Price Target
$335.38
▲(13.63% Upside)
Technical Analysis
Ownership Overview
6.78% Insiders
27.90% Mutual Funds
20.06% Other Institutional Investors
20.38% Public Companies and Individual Investors
Options Prices
Currently, No data available
---